1. Introduction
Obesity is a medical condition characterised by an abnormal fat accumulation, which may have adverse effects on health, thereby reducing life expectancy [
1]. Excess body weight is the sixth most important risk factor contributing to the overall burden of disease worldwide [
2]. In 2016, more than 1.9 billion adults aged 18 years and older were overweight. Of these, over 650 million adults were obese [
3]. Overweight and obesity have become a major public health problem in China [
4,
5]. A recent study showed that abdominal obesity is associated with insulin resistance and higher risks of metabolic syndrome and cardiovascular diseases in Asian females, whereas general obesity is not [
6]. Central obesity has been recognised as an independent risk factor for cardio-metabolic diseases and a better predictor of cardiovascular risk than overall obesity [
7,
8]. Defined by normal body mass index (BMI) and higher waist-to-height ratio, normal weight with central obesity (NWCO) has been recognised as a risk factor for cardio-metabolic diseases [
9]. The most common form of obesity is usually assessed by BMI [
10], which has the main limitation of not differentiating body fat from lean mass and central from peripheral fat. Therefore, athletes with enhanced body muscle mass may be misclassified as obese when using only BMI to diagnose obesity, whereas people with low lean mass but high body fat content may still have a normal BMI [
11]. By contrast, proxy measures of anthropometric indicators such as waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) are used to assess central fat distribution [
12]. WHtR is a better predictor than BMI and WC for diabetes, dyslipidemia, hypertension, and cardiovascular disease (CVD) [
13]. WHtR may be a simpler and better predictor of early health risks [
14,
15,
16,
17].
This study aims to estimate the prevalence of normal weight central obesity classified by using BMI and WHtR and to examine the relationship between normal weight with central obesity and CVD risk factors in adults in Shaanxi, China.
2. Materials and Methods
Subjects: A population-based cross-sectional survey was conducted among residents who were 18–80 years old and had been living in Zhenba County, Shaanxi Province, for over six months in 2018. The multistage stratified cluster sampling method was used to enroll the study’s participants. Six districts in Zhenba County, Shaanxi Province, were randomly selected, and then six communities were randomly selected from each district. All residents in the communities were invited to join this survey. Patients who were psychotic, debilitated, pregnant, or handicapped in any form to the point that obtaining anthropometric measurement would be difficult were excluded from the study. A consecutive sample of 3781 subjects aged over 18 years was recruited. Subjects with incomplete data due to height, weight, waist circumference, hypertension, dyslipidemia, and diabetes were excluded. A total of 2312 normal BMI participants were chosen for the study.
Data Collection: Data were obtained by face-to-face interviews composed of three parts: questionnaire investigation (included socio-demographic characteristics and health-related information), body measurements (such as height, weight, WC, and blood pressure), and laboratory measurements (such as serum cholesterol and triglyceride). Demographic variables including sex, age, level of education, cigarette smoking, coffee consumption, tea intake, and alcohol drinking were assessed by self-reporting on the use of any tobacco product or alcohol drinking in the past years. All investigators were trained by research assistants to collect data through the same questionnaire instruction.
Measurements: Height and weight were measured in increments of 0.1 cm and 0.1 kg, respectively, by trained staff. BMI was calculated as the weight (kg) divided by the squared height (m2). WC was measured to the nearest 0.1 cm at the umbilical level in a standing position. WHtR was calculated as WC divided by height. Omron automatic blood pressure machine was used to determine the subjects’ blood pressure on the right arm after at least 5 min of seated rest. Blood pressure was measured two times with intervals of at least one minute. The average value was used for data analysis. Fasting venous blood samples were drawn from the study subjects in order to measure serum levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides, and blood glucose. The samples were stored in a cooler at 4 °C for transportation to the Department of Laboratory Medicine, the First People’s Hospital of Zhenba County, and measured within 24 h of being drawn.
Definition of Related Indicators: BMI was categorised in accordance with the WHO’s criteria [
3] as underweight (<18.5 kg/m
2), normal (18.5–24.9 kg/m
2), overweight (25.0–29.9 kg/m
2), and obese (>30.0 kg/m
2). Central obesity was defined according to the WHO criteria [
18,
19]: WHtR < 0.5 (non-central obesity) and ≥0.5 (central obesity). Normal-weight central obesity was defined as central obesity in participants with normal weight (by BMI). The subjects were categorized into the following two groups: normal weight non central obesity (NWNO); and normal weight central obesity (NWCO). Underweight and overweight subjects (BMI < 18.5 and BMI ≥ 25.0 kg/m
2) were excluded from the study. Self-reported hypertensions and/or abnormal blood pressure (systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) were regarded as hypertension [
20]. The patient who had a history of hypertension and was currently taking medication for hypertension was also defined as having hypertension. Self-reported diabetes mellitus (DM) and/or a fasting serum glucose level ≥ 7.0 mmol/L were/was regarded as DM [
21]. The patient who had a history of diabetes and was currently taking medication for diabetes was also defined as having diabetes. According to the criteria of the “Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults,” hyperlipidemia diagnosed by a physician and/or abnormal blood lipids (TC ≥ 6.2 mmol/L or TG ≥ 2.3 mmol/L or HDL-C < 1.0 mmol/L) were defined as hyperlipidemia [
22].
Statistical Methods: Data were expressed as mean values ± standard deviations (SD) for continuous variables. Counts (frequencies = n) and proportions (%) were reported for categorical variables. Chi-squared test and Fisher’s exact probability method were used to compare categorical variables. The significant variables were included in the binary logistic regression and adjusted for confounding factors. Analysis was carried out at a 95% confidence level. Data were analyzed by the complex sampling function of SPSS 23.0 (IBM, New York, NY, United States), and a p value of < 0.05 was considered statistically significant.
3. Results
3.1. Univariate Analysis of Associated Factors of Normal Weight Central Obesity
In the study, we analyzed a total of 2312 participants (936 men and 1376 women). The mean age of the participants was 58.2 ± 13.1 years. Age groups were grouped according to a mean age of 58 years. The majority of the participants were elder people and females. Of the 2312 participants classified as normal weight using BMI, the prevalence of central obesity was 58.3% by WHtR. The characteristics of the two groups classified by WHtR (NWNO and NWCO) are shown in
Table 1. Among people with normal body mass index, the average age of NWCO group and NWNO group was 60.5 ± 12.1 years and 55.1 ± 13.9 years, respectively. The older the age, the higher the prevalence of central obesity. The prevalence in NWCO was 50.3% in men and 63.7% in women, respectively. The prevalence of NWCO was 68.3%, 74.2%, and 66.2% in hypertension, dyslipidemia, and diabetes, respectively. Central obesity was significantly associated with hypertension and dyslipidemia but not significant for DM among participants with normal weight, measured by BMI. Education, cigarette smoking, and coffee consumption were significantly associated with central obesity using WHtR. There were no significant correlations between central obesity and tea intake or alcohol drinking (
Table 1).
3.2. Logistic Regression Analysis of Associated Factors of Normal Weight Central Obesity
However, after adjusting for confounding factors (diabetes, alcohol drinking, tea intake, and coffee consumption), only female, age over 58 years, cigarette smoking, education, hypertension, and dyslipidemia were significantly associated with central obesity among the study participants. Female participants were 1.66 times more likely to be central obese than their male counterparts (
Table 2).
Logistic regression analysis was conducted in order to calculate the ORs (95% CIs) for hypertension, dyslipidemia, and other factors in each gender (
Table 3 for men and
Table 4 for women). When compared with NWNO, the adjusted ORs for hypertension (adjusted OR 1.47, 95% CI 1.10–1.98 in men; 1.55, 1.14–2.10 in women) and dyslipidemia (2.71, 1.77–4.13 in men; 1.84, 1.29–2.61 in women) had statistically significant associations in NWCO. In comparison with no cigarette smoking, daily cigarette smoking was associated with lower risk of NWCO. Adjusted OR for NWCO was 0.52 in males, 95% CI 0.40–0.68,
p < 0.001. Among females, there were no statistically significant associations with NWCO for either cigarette smoking or no cigarette smoking.
4. Discussion
In our study, the prevalence of NWCO defined using a combination of BMI and WHtR was 58.3%. As people become older, the risk of central obesity increases gradually. The prevalence of NWCO was higher in women than in men (63.7% vs. 50.3%). Normal weight with central obesity was associated with CVD risks such as hypertension and dyslipidemia in the present study, regardless of sex.
The higher prevalence of normal-weight central obesity found in this study suggests the need to include anthropometric indices in the measurement of excessive body weight other than BMI alone, as BMI alone might result in misclassifications and underestimation of at-risk individuals. This being the case, it is important to conduct screening for NWCO by using a combination of BMI and WHtR [
23]. Such individuals would normally need to be offered the appropriate health education and prompt intervention to manage and/or prevent the development of cardio-metabolic complications. At the same time, it also provides a new perspective for prevention of metabolic diseases: pay attention to your WHtR even when you have a normal BMI.
Only female sex, age over 58 years, cigarette smoking, education, hyperlipidemia, and hypertension were associated with central obesity. The association of central obesity with age and sex has been documented by several studies [
24]. The higher likelihood of being obese among females can be linked to women’s lower engagement in physical activity as well as the physiological changes that occur during their reproductive years [
25,
26]. Moreover, the distribution of fat in the body also changes after middle age: body fat is more likely to accumulate in the abdomen [
27]. This could also be a plausible reason for the higher prevalence of obesity among older participants. An inverse association was found between cigarette smoking and central obesity. In comparison with no cigarette smoking, daily cigarette smoking had an inverse association with the risk of NWCO. This is consistent with previous studies [
28,
29]. In addition, the cumulative effect of cigarette smoking on health is detrimental, regardless of its effect on weight loss. The majority of the study participants had low level education. There was significant correlation between central obesity and educational background. Central obesity has been shown to be associated with low education and socioeconomic status, which are characterised by poor health behaviour [
30,
31].
Hypertension and hyperlipidemia had a positive association with central obesity, which is consistent with previous studies [
32]. People with normal BMI but increased WC have a higher risk of developing metabolic diseases. Moreover, a study has also shown that measures of central obesity are more strongly associated with total and cardiovascular disease death than BMI [
16]. Central obesity was found to be strongly related to certain metabolic risk factors among non-obese subjects [
33]. In our study, although the prevalence of diabetes was higher in obese patients with normal BMI, no significant correlation between central obesity and hyperglycemia was detected. Our study demonstrates that normal-weight central obesity is associated with hypertension and hyperlipidemia. A previous study noted that central obesity among normal-weight individuals has been shown to be associated with a greater cardiovascular risk and mortality than is found among normal weight individuals without central obesity [
16]. Thus, blood glucose, blood lipid, and blood pressure should be detected early among adults with normal BMI in order to reduce the prevalence of hypertension, diabetes, and hyperlipidemia. Measuring waist circumference should be recommended as a simple and efficient tool for screening central obesity and related metabolic risks even in non-obese individuals. This highlights the need to include measures of central obesity in all clinical assessments in this study setting. Measures aimed at reducing obesity should be prioritised in order to curb the growing prevalence of chronic diseases, which impacts greatly the already over-burdened healthcare system.
The study still has some limitations. First, the cross-sectional nature of this study and the use of self-reported lifestyle behaviour inevitably produced recall bias. Second, the participants were recruited from Zhenba County in Shaanxi Province; thus, the conclusion cannot represent the situation in other regions of China. Thus, further studies, including prospective studies, will be required in order to establish causality. Finally, the sample size of this study was limited, and more confounding variables could not be adjusted.
5. Conclusions
The prevalence of central obesity is high in adults of normal weight. Sex, age, education, and cigarette smoking were closely related to central obesity among the study’s participants. The study suggests that using BMI alone as a measure of obesity is not enough for assessing health risks. In clinical practice, WHtR for measuring central obesity should be considered.
Author Contributions
W.-Y.F. contributed to the study design and conducted statistical analysis and manuscript writing. Q.L. was responsible for careful review of protocol, design, methodology, and provided continuous scientific advice for the study. J.L. assisted with the interpretation of the data. W.-Y.F. and X.-D.L. conceived the article. Q.L., Y.S., X.-D.L. and J.L. were involved in the manuscript’s review. All authors have read and agreed to the published version of the manuscript.
Funding
This research is supported by National Key R&D Program of China (Grant No: 2017YFC0907200, 2017YFC0907201and2017YFC0907202).
Institutional Review Board Statement
We obtained written informed consent of all the participants. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Xi’an Jiaotong University (protocol code XJTU-2017-0008).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Acknowledgments
We thank all study participants and staff in each of the study sites and communities, including Zhenba Provincial Center for Disease Prevention and Control.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Haslam, D.W.; James, W.P. Obesity. Lancet 2005, 366, 1197–1209. [Google Scholar] [CrossRef]
- McMillen, I.C.; Rattanatray, L.; Duffield, J.A.; Morrison, J.L.; MacLaughlin, S.M.; Gentili, S.; Muhlhausler, B.S. The early origins of later obesity: Pathways and mechanisms. Adv. Exp. Med. Biol. 2009, 646, 71–81. [Google Scholar] [CrossRef]
- World Health Organization. Obesity and Overweight. Available online: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight (accessed on 10 February 2021).
- Jaacks, L.M.; Gordon-Larsen, P.; Mayer-Davis, E.J.; Adair, L.S.; Popkin, B. Age, period and cohort effects on adult body mass index and overweight from 1991 to 2009 in China: The China Health and Nutrition Survey. Int. J. Epidemiol. 2013, 42, 828–837. [Google Scholar] [CrossRef] [Green Version]
- Flegal, K.M.; Kit, B.K.; Orpana, H.; Graubard, B.I. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 2013, 309, 71–82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goh, V.H.H.; Hart, W.G. Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women. Maturitas 2018, 107, 33–38. [Google Scholar] [CrossRef]
- Cameron, A.J.; Magliano, D.J.; Shaw, J.E.; Zimmet, P.Z.; Carstensen, B.; Alberti, K.G.M.; Tuomilehto, J.; Barr, E.L.M.; Pauvaday, V.K.; Kowlessur, S.; et al. The influence of hip circumference on the relationship between abdominal obesity and mortality. Int. J. Epidemiol. 2012, 41, 484–494. [Google Scholar] [CrossRef]
- Piché, M.E.; Poirier, P.; Lemieux, I.; Després, J.P. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog. Cardiovasc. Dis. 2018, 61, 103–113. [Google Scholar] [CrossRef]
- Thaikruea, L.; Thammasarot, J. Prevalence of normal weight central obesity among Thai healthcare providers and their association with CVD risk: A cross-sectional study. Sci. Rep. 2016, 6, 37100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Adab, P.; Pallan, M.; Whincup, P.H. Is BMI the best measure of obesity? BMJ 2018, 360, k1274. [Google Scholar] [CrossRef] [Green Version]
- Romero-Corral, A.; Somers, V.K.; Sierra-Johnson, J.; Korenfeld, Y.; Boarin, S.; Korinek, J.; Jensen, M.D.; Parati, G.; Lopez-Jimenez, F. Normal weight obesity: A risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur. Heart J. 2010, 31, 737–746. [Google Scholar] [CrossRef]
- Wiltink, J.; Michal, M.; Wild, P.S.; Zwiener, I.; Blettner, M.; Münzel, T.; Schulz, A.; Kirschner, Y.; Beutel, M.E. Associations between depression and different measures of obesity (BMI, WC, WHtR, WHR). BMC Psychiatry 2013, 13, 223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ashwell, M.; Gunn, P.; Gibson, S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes. Rev. 2012, 13, 275–286. [Google Scholar] [CrossRef]
- Hsieh, S.D.; Muto, T. Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev. Med. 2006, 42, 135–139. [Google Scholar] [CrossRef]
- Tatsumi, Y.; Watanabe, M.; Kokubo, Y.; Nishimura, K.; Higashiyama, A.; Okamura, T.; Okayama, A.; Miyamoto, Y. Effect of age on the association between waist-to-height ratio and incidence of cardiovascular disease: The Suita study. J. Epidemiol. 2013, 23, 351–359. [Google Scholar] [CrossRef] [Green Version]
- Sahakyan, K.R.; Somers, V.K.; Rodriguez-Escudero, J.P.; Hodge, D.O.; Carter, R.E.; Sochor, O.; Coutinho, T.; Jensen, M.D.; Roger, V.L.; Singh, P.; et al. Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann. Intern. Med. 2015, 163, 827–835. [Google Scholar] [CrossRef] [Green Version]
- Ashwell, M.; Gibson, S. Waist-to-height ratio as an indicator of ‘early health risk’: Simpler and more predictive than using a ‘matrix’ based on BMI and waist circumference. BMJ Open 2016, 6, e010159. [Google Scholar] [CrossRef] [Green Version]
- Browning, L.M.; Hsieh, S.D.; Ashwell, M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr. Res. Rev. 2010, 23, 247–269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wakabayashi, I. Necessity of both waist circumference and waist-to-height ratio for better evaluation of central obesity. Metab. Syndr. Relat. Disord. 2013, 11, 189–194. [Google Scholar] [CrossRef]
- Liu, L.S. Joint Committee for Guideline Revision. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J. Geriatr. Cardiol. 2019, 16, 182–241. [Google Scholar] [CrossRef]
- Weng, J.; Ji, L.; Jia, W.; Lu, J.; Zhou, Z.; Zou, D.; Zhu, D.; Chen, L.; Chen, L.; Guo, L.; et al. Standards of care for type 2 diabetes in China. Diabetes Metab. Res. Rev. 2016, 32, 442–458. [Google Scholar] [CrossRef] [PubMed]
- Joint Committee for Guideline Revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J. Geriatr. Cardiol. 2018, 15, 1–29. [Google Scholar] [CrossRef]
- Mirzaei, M.; Khajeh, M. Comparison of anthropometric indices (body mass index, waist circumference, waist to hip ratio and waist to height ratio) in predicting risk of type II diabetes in the population of Yazd, Iran. Diabetes Metab. Syndr. 2018, 12, 677–682. [Google Scholar] [CrossRef] [PubMed]
- Ford, E.S.; Maynard, L.M.; Li, C. Trends in mean waist circumference and abdominal obesity among US adults, 1999–2012. JAMA 2014, 312, 1151–1153. [Google Scholar] [CrossRef] [Green Version]
- Sumithran, P.; Houlihan, C.; Shub, A.; Churilov, L.; Pritchard, N.; Price, S.; Ekinci, E.; Proietto, J.; Permezel, M. How common is substantial weight gain after pregnancy? Obes. Res. Clin. Pract. 2018, 12, 139–145. [Google Scholar] [CrossRef]
- Gunderson, E.P. Childbearing and obesity in women: Weight before, during, and after pregnancy. Obstet Gynecol. Clin. North Am. 2009, 36, 317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tchernof, A.; Després, J.P. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 2013, 93, 359–404. [Google Scholar] [CrossRef]
- Courtemanche, C.; Tchernis, R.; Ukert, B. The effect of smoking on obesity: Evidence from a randomized trial. J. Health Econ. 2018, 57, 31–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mackay, D.F.; Gray, L.; Pell, J.P. Impact of smoking and smoking cessation on overweight and obesity: Scotland-wide, cross-sectional study on 40,036 participants. BMC Public Health 2013, 13, 348. [Google Scholar] [CrossRef] [Green Version]
- Camões, M.; Lopes, C.; Oliveira, A.; Santos, A.C.; Barros, H. Overall and central obesity incidence in an urban Portuguese population. Prev. Med. 2010, 50, 50–55. [Google Scholar] [CrossRef]
- Du, T.; Sun, X.; Yin, P.; Huo, R.; Ni, C.; Yu, X. Increasing trends in central obesity among Chinese adults with normal body mass index, 1993–2009. BMC Public Health 2013, 13, 327. [Google Scholar] [CrossRef] [Green Version]
- Zhou, X.; Ji, L.; Ran, X.; Su, B.; Ji, Q.; Pan, C.; Weng, J.; Ma, C.; Hao, C.; Zhang, D.; et al. Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study. PLoS ONE 2016, 11, e0144179. [Google Scholar] [CrossRef] [PubMed]
- Lukács, A.; Horváth, E.; Máté, Z.; Szabó, A.; Virág, K.; Papp, M.; Sándor, J.; Ádány, R.; Paulik, E. Abdominal obesity increases metabolic risk factors in non-obese adults: A Hungarian cross-sectional study. BMC Public Health 2019, 19, 1533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table 1.
Comparison of the prevalence of central obesity in participants under different groups of associated factors (Chi-square test are applied).
Table 1.
Comparison of the prevalence of central obesity in participants under different groups of associated factors (Chi-square test are applied).
| NWCO | NWNO | χ2 | p |
---|
Age | | | | |
<58 | 525 (50.9) | 507 (49.1) | 41.853 | <0.001 |
≥58 | 822 (64.2) | 458 (35.8) | | |
Sex | | | | |
Male | 471 (50.3) | 465 (49.7) | 40.780 | <0.001 |
Female | 876 (63.7) | 500 (36.3) | | |
Hypertension | | | | |
Yes | 424 (68.3) | 197 (31.7) | 35.025 | <0.001 |
No | 923 (54.6) | 768 (45.4) | | |
Dyslipidemia | | | | |
Yes | 256 (74.2) | 89 (25.8) | 42.379 | <0.001 |
No | 1091 (55.5) | 876 (44.5) | | |
Diabetes | | | | |
Yes | 96 (66.2) | 49 (33.8) | 4.016 | 0.045 |
No | 1251 (57.7) | 916 (42.3) | | |
Tea intake | | | | |
Yes | 725 (57.8) | 529 (42.2) | 0.224 | 0.636 |
No | 622 (58.8) | 436 (41.2) | | |
Coffee consumption | | | | |
Yes | 26 (44.8) | 32 (55.2) | 4.415 | 0.036 |
No | 1321 (58.6) | 933 (41.4) | | |
Alcohol drinking | | | | |
Yes | 266 (56.7) | 203 (43.3) | 0.577 | 0.447 |
No | 1081 (58.7) | 762 (41.3) | | |
Cigarette smoking | | | | |
None | 1092 (61.7) | 677 (38.3) | 50.871 | <0.001 |
Few times | 43 (64.2) | 24 (35.8) | | |
Sometimes | 10 (71.4) | 4 (28.6) | | |
Daily | 202 (43.7) | 260 (56.3) | | |
Education | | | | |
Primary school and below | 584 (66.2) | 298 (33.8) | 47.496 | <0.001 |
Junior middle school | 461 (55.4) | 371 (4.6) | | |
Senior middle school | 201 (48.9) | 210 (51.1) | | |
College | 84 (58.7) | 59 (41.3) | | |
High than college | 17 (38.6) | 27 (61.4) | | |
Table 2.
Logistic regression showing predictors of normal weight central obesity.
Table 2.
Logistic regression showing predictors of normal weight central obesity.
Variables | β | Wald χ2 | p | OR (95%CL) |
---|
Age ≥ 58 | 0.52 | 26.39 | <0.001 | 1.69 (1.38, 2.06) |
Sex = Female | 0.46 | 15.43 | <0.001 | 1.59 (1.26, 2.00) |
Hypertension | 0.43 | 15.71 | <0.001 | 1.53 (1.24, 1.89) |
Dyslipidemia | 0.79 | 32.48 | <0.001 | 2.19 (1.68, 2.88) |
Cigarette smoking | | 27.65 | <0.001 | |
None | | | | 1.00 |
Few times | 0.22 | 0.61 | 0.433 | 1.24 (0.72, 2.13) |
Sometimes | 0.44 | 0.52 | 0.473 | 1.56 (0.46, 5.24) |
Daily | −0.67 | 23.10 | <0.001 | 0.51 (0.39, 0.67) |
Education | | 10.37 | 0.035 | |
Primary school and below | | | | 1.00 |
Junior middle school | −0.18 | 2.91 | 0.088 | 0.83 (0.68, 1.03) |
Senior middle school | −0.34 | 6.31 | 0.012 | 0.71 (0.55, 0.93) |
College | 0.03 | 0.02 | 0.884 | 1.03 (0.70, 1.52) |
High than college | −0.68 | 4.09 | 0.043 | 0.51(0.26,0.98) |
Table 3.
Logistic regression showing predictors of normal weight central obesity in males.
Table 3.
Logistic regression showing predictors of normal weight central obesity in males.
Variables | β | Wald χ2 | p | OR (95%CL) |
---|
Age ≥ 58 | 0.58 | 13.13 | <0.001 | 1.78 (1.30, 2.44) |
Hypertension | 0.39 | 6.56 | 0.010 | 1.47 (1.10, 1.98) |
Dyslipidemia | 1.00 | 21.25 | <0.001 | 2.71 (1.77, 4.13) |
Cigarette smoking | | 21.70 | <0.001 | |
None | | | | 1.00 |
Few times | 0.19 | 0.33 | 0.564 | 1.21 (0.64, 2.29) |
Sometimes | 0.24 | 0.15 | 0.704 | 1.28 (0.36, 4.49) |
Daily | −0.64 | 18.28 | <0.001 | 0.53 (0.39, 0.71) |
Education | | 9.84 | 0.043 | |
Primary school and below | | | | 1.00 |
Junior middle school | −0.02 | 0.01 | 0.915 | 0.98 (0.70, 1.37) |
Senior middle school | −0.15 | 0.58 | 0.448 | 0.86 (0.58, 1.27) |
College | 0.76 | 6.42 | 0.011 | 2.14 (1.19, 3.86) |
High than college | −0.24 | 0.25 | 0.619 | 0.79 (0.30, 2.04) |
Table 4.
Logistic regression showing predictors of normal weight central obesity in females.
Table 4.
Logistic regression showing predictors of normal weight central obesity in females.
Variables | β | Wald χ2 | p | OR (95%CL) |
---|
Age ≥ 58 | 0.49 | 12.47 | <0.001 | 1.62 (1.24, 2.13) |
Hypertension | 0.44 | 7.87 | 0.005 | 1.55 (1.14, 2.10) |
Dyslipidemia | 0.61 | 11.37 | 0.001 | 1.84 (1.29, 2.61) |
Education | | 11.64 | 0.020 | |
Primary school and below | | | | 1.00 |
Junior middle school | −0.28 | 3.83 | 0.050 | 0.76 (0.58, 1.00) |
Senior middle school | −0.45 | 5.86 | 0.015 | 0.64 (0.44, 0.92) |
College and above | −0.59 | 4.59 | 0.032 | 0.56 (0.33, 0.95) |
High than college | −1.09 | 5.13 | 0.023 | 0.34 (0.13, 0.86) |
Cigarette smoking | | 4.08 | 0.253 | |
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).